Long-term follow-up of salvage radiotherapy in Hodgkin’s lymphoma after chemotherapy failure
Authors:
- Andrew WirthAWAndrew Wirth
- Alvin MilnerAMAlvin Milner
- Juliana Di IulioJIJuliana Di Iulio
- Michael MacManusMMMichael MacManus
- Gail RyanGRGail Ryan
- 1 December 2005
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 63 (5) , 1538-1545
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Salvage Radiotherapy in Patients With Relapsed and Refractory Hodgkin’s Lymphoma: A Retrospective Analysis From the German Hodgkin Lymphoma Study GroupJournal of Clinical Oncology, 2005
- Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy‐proven primary refractory Hodgkin's diseaseBritish Journal of Haematology, 2004
- Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 2003
- Hodgkin’s Lymphoma: Biology and Treatment Strategies for Primary, Refractory, and Relapsed DiseaseHematology-American Society Hematology Education Program, 2003
- Hodgkin's disease: treatment of relapsed diseaseAnnals of Oncology, 2002
- Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study GroupBlood, 2000
- Radiation therapy as a component of high-dose salvage strategies in Hodgkin’s diseaseAnnals of Oncology, 1998
- Salvage radiotherapy for hodgkin's disease following chemotherapy failureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's diseaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trialThe Lancet, 1993